DOI QR코드

DOI QR Code

Association of Genetic Polymorphisms at 1q22 but not 10q23 with Gastric Cancer in a Southern Chinese Population

  • Yang, Xue-Xi (School of Biotechnology, Southern Medical University) ;
  • Li, Fen-Xia (School of Biotechnology, Southern Medical University) ;
  • Zhou, Cui-Ping (The First Clinical College, Southern Medical University) ;
  • Hu, Ni-Ya (Department of Clinical, First Affiliated Hospital of Nanchang University) ;
  • Wu, Ying-Shong (School of Biotechnology, Southern Medical University) ;
  • Li, Ming (School of Biotechnology, Southern Medical University)
  • Published : 2012.06.30

Abstract

Objective: Data from a recent genome-wide association studiesy of gastric cancer (GC) and oesophageal squamous cell carcinoma in Chinese living in the Taihang Mountains of north-central China suggest that 1q22 and 10q23 are susceptibility-associated regions for GC. However, this has not been confirmed in southern Chinese populations. The aim of this study was to investigate whether these polymorphisms at 1q22 and 10q23 are associated with the risk of GC in a southern Chinese population. Methods: We selected seven top significant associated single nucleotide polymorphisms (SNPs) at 1q22 and 10q23 and conducted a population-based case-control study in a southern Chinese population. Genotypes were determined using MassARRAYTM system (Sequenome, San Diego, CA). Results: Two SNPs at 1q22, rs4072037 and rs4460629, were significantly associated with a reduced risk of GC, best fitting the dominant genetic model. Logistic regression models adjusted for age and sex showed that rs4072037 AG and GG (OR=0.64, P=0.017, compared with AA) and rs4460629 CT and TT (OR=0.54, P=0.0016, compared with TT) significantly reduced the risk of GC. However, no significant results for the five SNPs at 10q23 were obtained in this study. Conclusion: These outcomes indicate that 1q22 is associated with GC susceptibility in this southern Chinese population, while an association for the locus at 10q23 was not confirmed.

Keywords

References

  1. Abnet CC, Freedman ND, Hu N, et al (2010). A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet, 42, 764-7. https://doi.org/10.1038/ng.649
  2. Bai Y, Edamatsu H, Maeda S, et al (2004). Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Cancer Res, 64, 8808-10. https://doi.org/10.1158/0008-5472.CAN-04-3143
  3. Blaser MJ (2000). Linking Helicobacter pylori to gastric cancer. Nat Med, 6, 376-7. https://doi.org/10.1038/74627
  4. Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P (2006). Hyaluronan-CD44 interaction with leukemiaassociated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem, 281, 14026-40. https://doi.org/10.1074/jbc.M507734200
  5. Bunney TD, Baxendale RW, Katan M (2009). Regulatory links between PLC enzymes and Ras superfamily GTPases: signalling via PLC epsilon. Adv Enzyme Regul, 49, 54-8. https://doi.org/10.1016/j.advenzreg.2009.01.004
  6. Burton PR, Clayton DG, Cardon LR, et al (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-78. https://doi.org/10.1038/nature05911
  7. Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62.
  8. Gonzalez CA, Sala N, Capella G (2002). Genetic susceptibility and gastric cancer risk. Int J Cancer, 100, 249-60. https://doi.org/10.1002/ijc.10466
  9. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  10. Jia Y, Persson C, Hou L, et al (2010). A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control, 21, 313-21. https://doi.org/10.1007/s10552-009-9463-3
  11. Li X, Yang XX, Hu NY, et al (2011). A risk-associated single nucleotide polymorphism of SMAD7 is common to colorectal, gastric, and lung cancers in a Han Chinese population. Mol Biol Rep, 38, 5093-7. https://doi.org/10.1007/s11033-010-0656-3
  12. Linden S, Mahdavi J, Hedenbro J, Boren T, Carlstedt I (2004). Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins. Biochem J, 384, 263-70. https://doi.org/10.1042/BJ20040402
  13. McGuckin MA, Every AL, Skene CD, et al (2007). Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology, 133, 1210-8. https://doi.org/10.1053/j.gastro.2007.07.003
  14. McNab FW, Rajsbaum R, Stoye JP, O'Garra A (2011). Tripartitemotif proteins and innate immune regulation. Curr Opin Immunol, 23, 46-56. https://doi.org/10.1016/j.coi.2010.10.021
  15. Ng W, Loh AX, Teixeira AS, Pereira SP, Swallow DM (2008). Genetic regulation of MUC1 alternative splicing in human tissues. Br J Cancer, 99, 978-85. https://doi.org/10.1038/sj.bjc.6604617
  16. Peek RM Jr, Blaser MJ (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer, 2, 28-37. https://doi.org/10.1038/nrc703
  17. Sakamoto H, Yoshimura K, Saeki N, et al (2008). Genetic variation in PSCA is associated with susceptibility to diffusetype gastric cancer. Nat Genet, 40, 730-40. https://doi.org/10.1038/ng.152
  18. Taylor-Papadimitriou J, Burchell JM, Plunkett T, et al (2002). MUC1 and the immunobiology of cancer. J Mammary Gland Biol Neoplasia, 7, 209-21. https://doi.org/10.1023/A:1020360121451
  19. Vinall LE, King M, Novelli M, et al (2002). Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology, 123, 41-9. https://doi.org/10.1053/gast.2002.34157
  20. Xu Q, Yuan Y, Sun LP, et al (2009). Risk of gastric cancer is associated with the MUC1 568 A/G polymorphism. Int J Oncol, 35, 1313-20.
  21. Zhang H, Jin G, Li H, et al (2011). Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population. Carcinogenesis, 32, 848-52. https://doi.org/10.1093/carcin/bgr051

Cited by

  1. Genome network medicine: innovation to overcome huge challenges in cancer therapy vol.6, pp.2, 2013, https://doi.org/10.1002/wsbm.1254
  2. Helicobacter pylori Infection Synergizes with Three Inflammation-Related Genetic Variants in the GWASs to Increase Risk of Gastric Cancer in a Chinese Population vol.8, pp.9, 2013, https://doi.org/10.1371/journal.pone.0074976
  3. Common genetic variants at 1q22 and 10q23 and gastric cancer susceptibility in a Korean population vol.35, pp.4, 2014, https://doi.org/10.1007/s13277-013-1409-4
  4. Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer vol.4, pp.1, 2015, https://doi.org/10.1038/srep04143
  5. and Susceptibility to Digestive Tract Cancer in the Chinese Population: A Meta-Analysis vol.29, pp.4, 2014, https://doi.org/10.5301/jbm.5000090
  6. MUC1 rs4072037 Polymorphism is Associated with Decreased Risk of Gastric Cancer: A Meta-analysis vol.32, pp.3, 2017, https://doi.org/10.5301/ijbm.5000270
  7. MUC1, MUC5AC, and MUC6 polymorphisms, Helicobacter pylori infection, and gastric cancer pp.0959-8278, 2017, https://doi.org/10.1097/CEJ.0000000000000348
  8. MUC1 gene polymorphism rs4072037 and susceptibility to gastric cancer: a meta-analysis vol.3, pp.1, 2014, https://doi.org/10.1186/2193-1801-3-599
  9. rs2274223 variant and digestive tract cancer: A meta-analysis pp.23249269, 2019, https://doi.org/10.1002/mgg3.589